PCSK9 Inhibitors

Cell

Volumn 165, Issue 5, 2016, Pages 1037-

  Natarajan, Pradeep ^a,b,c   Kathiresan, Sekar ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIROCUMAB; EVOLOCUMAB; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY; PROPROTEIN CONVERTASE 9; HYPOCHOLESTEROLEMIC AGENT;

ATHEROSCLEROSIS; DRUG APPROVAL; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT SURVEY; BLOOD;

ANTIBODIES, MONOCLONAL; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; HUMANS;

EID: 85014244905     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.05.016     Document Type: Short Survey

References (10)

1. Abifadel, M., Varret, M., Rabès, J.P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., et al. Nat. Genet. 34 (2003), 154–156.
2. Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr., Hobbs, H.H., N. Engl. J. Med. 354 (2006), 1264–1272.
3. Horton, J.D., Shah, N.A., Warrington, J.A., Anderson, N.N., Park, S.W., Brown, M.S., Goldstein, J.L., Proc. Natl. Acad. Sci. USA 100 (2003), 12027–12032.
4. Lagace, T.A., Curtis, D.E., Garuti, R., McNutt, M.C., Park, S.W., Prather, H.B., Anderson, N.N., Ho, Y.K., Hammer, R.E., Horton, J.D., J. Clin. Invest. 116 (2006), 2995–3005.
5. Maxwell, K.N., Breslow, J.L., Proc. Natl. Acad. Sci. USA 101 (2004), 7100–7105.
6. Maxwell, K.N., Soccio, R.E., Duncan, E.M., Sehayek, E., Breslow, J.L., J. Lipid Res. 44 (2003), 2109–2119.
7. Naureckiene, S., Ma, L., Sreekumar, K., Purandare, U., Lo, C.F., Huang, Y., Chiang, L.W., Grenier, J.M., Ozenberger, B.A., Jacobsen, J.S., et al. Arch. Biochem. Biophys. 420 (2003), 55–67.
8. Robinson, J.G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E.S., Langslet, G., Raal, F.J., El Shahawy, M., et al., ODYSSEY LONG TERM Investigators. N. Engl. J. Med. 372 (2015), 1489–1499.
9. Sabatine, M.S., Giugliano, R.P., Wiviott, S.D., Raal, F.J., Blom, D.J., Robinson, J., Ballantyne, C.M., Somaratne, R., Legg, J., Wasserman, S.M., et al., Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. N. Engl. J. Med. 372 (2015), 1500–1509.
10. Seidah, N.G., Benjannet, S., Wickham, L., Marcinkiewicz, J., Jasmin, S.B., Stifani, S., Basak, A., Prat, A., Chretien, M., Proc. Natl. Acad. Sci. USA 100 (2003), 928–933.